Holen Sie sich die Stockscreener-App
9.14
1.11%
0.10
Handel nachbörslich:
9.14
Schlusskurs vom Vortag:
$9.04
Offen:
$9.18
24-Stunden-Volumen:
2.09M
Relative Volume:
1.12
Marktkapitalisierung:
$1.33B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-174.61M
KGV:
-4.6396
EPS:
-1.97
Netto-Cashflow:
$-165.54M
1W Leistung:
-3.59%
1M Leistung:
-16.91%
6M Leistung:
-14.74%
1J Leistung:
+13.97%
1-Tages-Spanne:
$9.08
$9.50
1-Wochen-Bereich:
$8.4207
$9.50
52-Wochen-Spanne:
$4.16
$11.84
89 Bio Inc Stock (ETNB) Company Profile
Firmenname
89 Bio Inc
Sektor
Branche
Telefon
(415) 432-9270
Adresse
655 MONTGOMERY STREET, SAN FRANCISCO, CA
Vergleichen Sie ETNB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
9.14 | 1.30B | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-14 | Eingeleitet | Goldman | Neutral |
| 2025-03-13 | Eingeleitet | Citigroup | Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2024-04-22 | Fortgesetzt | BofA Securities | Buy |
| 2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2023-08-28 | Eingeleitet | UBS | Buy |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2022-05-12 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-26 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-07-29 | Fortgesetzt | BTIG Research | Buy |
| 2021-05-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-10-19 | Eingeleitet | Raymond James | Strong Buy |
| 2020-09-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-31 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-23 | Eingeleitet | BTIG Research | Buy |
| 2020-07-07 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-12-09 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-12-09 | Eingeleitet | Oppenheimer | Outperform |
| 2019-12-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-12-09 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
89 Bio Inc Aktie (ETNB) Neueste Nachrichten
What makes 89bio Inc. stock price move sharplyBond Market & Real-Time Stock Movement Alerts - Newser
Chart based exit strategy for 89bio Inc.Sell Signal & Real-Time Buy Zone Alerts - Newser
How to read the order book for 89bio Inc.July 2025 Breakouts & Verified Entry Point Signals - Newser
89bio Inc. recovery potential after sell off [Portfolio Update Summary]Accurate Entry and Exit Point Alerts - Newser
89bio Inc. recovery potential after sell offBuy Candidate Summary Based on Fundamentals - Newser
89Bio Inc. Faces Financial Uncertainty Amid Potential U.S. Tax Law Changes - TipRanks
How 89bio Inc. stock performs during market volatilityChart Pattern Strategy with ROI Focus - Newser
Can trapped investors hope for a rebound in 89bio Inc.Retirement Investment Outlook and Return Summary - Newser
Quantitative breakdown of 89bio Inc. recent moveLow Risk Strategy with Smart Entry Zones - Newser
Evaluating 89bio Inc. with trendline analysisBuy Strategy with Smart Exit Timing - Newser
Analyzing recovery setups for 89bio Inc. investorsFree Real Time Alerts Based on AI Prediction - Newser
89bio: Promising As Pegozafermin Nears Phase 3 Readout (NASDAQ:ETNB) - Seeking Alpha
Signal strength of 89bio Inc. stock in tech scannersFree Community Verified Stock Suggestions - Newser
How to track smart money flows in 89bio Inc.Free Intraday Trend Analysis for Fast Gains - Newser
Statistical indicators supporting 89bio Inc.’s strengthValue Investing Summary and Earnings Outlook - Newser
Advanced analytics toolkit walkthrough for 89bio Inc.Risk Balanced Picks for Safer Trading - Newser
How moving averages guide 89bio Inc. tradingAI Trade Signal Forecast with Chart Logic - Newser
89Bio Inc. Faces Financial Uncertainty Amid U.S. Tax Law Changes - AInvest
Using Bollinger Bands to evaluate 89bio Inc.Momentum Detection with Entry Optimization - Newser
What institutions are buying 89bio Inc. stock nowFree Pattern Alert With ROI Driven Strategy - Newser
What moving averages say about 89bio Inc.Predictive System for Long-Term Stock Forecast - Newser
89bio, Inc. SEC 10-Q Report - TradingView
89Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
89bio (ETNB) Q2 R&D Jumps 131% - The Motley Fool
89Bio Inc.’s ENTRUST Study: A Potential Game-Changer in Hypertriglyceridemia Treatment - TipRanks
89bio Reports Second Quarter 2025 Financial Results and Corporate Updates - The Manila Times
89bio Q2 Earnings Reveal Massive $561M War Chest for Game-Changing MASH Treatment Trials - Stock Titan
Custom strategy builders for tracking 89bio Inc.Near-Term Market Opportunity Forecast Sheet - Newser
Can 89bio Inc. stock recover from recent declineEarly Entry Planner for Swing Candidates - Newser
Allianz Asset Management GmbH Invests $93,000 in 89BIO (NASDAQ:ETNB) - Defense World
How to monitor 89bio Inc. with trend dashboardsFree Capital Efficiency Optimized Stock Alerts - Newser
Finanzdaten der 89 Bio Inc-Aktie (ETNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):